On June 8, 2025, Maravai LifeSciences Holdings, Inc. appointed Bernd Brust as the new CEO, succeeding William E. Martin, who resigned from the Board. Brust's new role includes an annual salary of $750,000 and significant stock options, totaling 1,000,000 shares.